LINC01195

Across TCGA pan-cancer cohorts, LINC01195 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC01195 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC01195 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01195 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LAML show a favorable association.

LUAD, KIRC, and BLCA are the cancer types where LINC01195 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.324	0.758	<.001	93	view →
KIRC	DFS	Tertile	All	0.657	0.814	.007	78	view →
BLCA	DFS	Tertile	All	0.216	0.617	.005	45	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	36	view →
ESCA	OS	Tertile	III,IV	0.724	0.354	.022	33	view →
SKCM	OS	Tertile	II,III,IV	0.477	0.739	.018	33	view →
LUSC	OS	Tertile	II,III,IV	0.252	0.618	.021	30	view →
DLBC	DFS	Tertile	All	0.399	0.796	.032	18	view →
LAML	DFS	Tertile	All	1.000	0.361	.039	18	view →
THCA	DFS	Tertile	II,III,IV	0.794	0.932	.044	6	view →
LIHC	OS	Tertile	III,IV	1.000	0.617	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC01195–LUAD (OS)

Open the LUAD breakdown →